Calamos Advisors LLC Amphastar Pharmaceuticals, Inc. Transaction History

Calamos Advisors LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$44.49 - $62.93 $866,620 - $1.23 Million	19,479 New	19,479 $1.2 Million
Q2 2022 Aug 01, 2022	BUY	$29.79 - $42.29 $187,647 - $266,384	6,299 Added 6.66%	100,942 $3.51 Million
Q1 2022 May 03, 2022	BUY	$22.96 - $36.45 $2.17 Million - $3.45 Million	94,643 New	94,643 $3.4 Million

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.